1. Home
  2. BOLT vs TIRX Comparison

BOLT vs TIRX Comparison

Compare BOLT & TIRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BOLT
  • TIRX
  • Stock Information
  • Founded
  • BOLT 2015
  • TIRX 2010
  • Country
  • BOLT United States
  • TIRX China
  • Employees
  • BOLT N/A
  • TIRX N/A
  • Industry
  • BOLT Biotechnology: Pharmaceutical Preparations
  • TIRX Specialty Insurers
  • Sector
  • BOLT Health Care
  • TIRX Finance
  • Exchange
  • BOLT Nasdaq
  • TIRX Nasdaq
  • Market Cap
  • BOLT 16.8M
  • TIRX 14.0M
  • IPO Year
  • BOLT 2021
  • TIRX 2021
  • Fundamental
  • Price
  • BOLT $5.69
  • TIRX $1.27
  • Analyst Decision
  • BOLT Buy
  • TIRX
  • Analyst Count
  • BOLT 3
  • TIRX 0
  • Target Price
  • BOLT $50.00
  • TIRX N/A
  • AVG Volume (30 Days)
  • BOLT 23.5K
  • TIRX 1.2M
  • Earning Date
  • BOLT 08-12-2025
  • TIRX 08-15-2025
  • Dividend Yield
  • BOLT N/A
  • TIRX N/A
  • EPS Growth
  • BOLT N/A
  • TIRX N/A
  • EPS
  • BOLT N/A
  • TIRX N/A
  • Revenue
  • BOLT $3,638,000.00
  • TIRX $3,219,336.00
  • Revenue This Year
  • BOLT N/A
  • TIRX N/A
  • Revenue Next Year
  • BOLT $24.14
  • TIRX N/A
  • P/E Ratio
  • BOLT N/A
  • TIRX N/A
  • Revenue Growth
  • BOLT N/A
  • TIRX 158.74
  • 52 Week Low
  • BOLT $5.20
  • TIRX $1.07
  • 52 Week High
  • BOLT $15.60
  • TIRX $4.15
  • Technical
  • Relative Strength Index (RSI)
  • BOLT 42.69
  • TIRX 42.99
  • Support Level
  • BOLT $5.36
  • TIRX $1.20
  • Resistance Level
  • BOLT $6.07
  • TIRX $1.45
  • Average True Range (ATR)
  • BOLT 0.44
  • TIRX 0.07
  • MACD
  • BOLT -0.01
  • TIRX -0.01
  • Stochastic Oscillator
  • BOLT 25.58
  • TIRX 29.63

About BOLT Bolt Biotherapeutics Inc.

Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on our deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.

About TIRX TIAN RUIXIANG Holdings Ltd

Tian Ruixiang Holdings Ltd is an Insurance Brokerage firm. It distributes a wide range of insurance products, which are categorized into two groups; property and casualty insurance, such as commercial property insurance, liability insurance, accidental insurance, and automobile insurance; and other insurances, such as health insurance, life insurance, and miscellaneous insurances. It also generates a small amount of revenue from risk management services. The firm act on behalf of its customers seeking insurance coverage from insurance companies. It generates revenue from the provision of insurance brokerage services.

Share on Social Networks: